BIOMARKERS FOR MONITORING TREATMENT RESPONSE AND CHANGES IN THE MOLECULAR MAKEUP OF GLIOBLASTOMA ARE LIMITED. PROJECT WILL USE GENOMIC ANALYSES OF RESECTED TUMORS AND PERIPHERAL PLASMA SAMPLES TO ASSESS THE FEASIBILITY OF CIRCULATING DNA-BASED DIAGNOSTICS IN PATIENTS WITH GLIOBLASTOMA.

PI: Muhammed Murtaza, Ph.D.
Co-Director, Center for Noninvasive Diagnostics
Translational Genomics Research Institute (TGen)

Close Menu